References
- Nutanson I, Steen CJ, Schwartz RA, Janniger CK. Pediculus humanus capitis: An update. Acta Dermatovenerol Alp Panonica Adriat. 2008;17:147–154.
- Heymann WR. Head lice treatments: Searching for the path of least resistance. J Am Acad Dermatol. 2009;61:323–324.
- Chosidow O, Giraudeau B, Cottrell J, Izri A, Hofmann R, Mann SG, Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med. 2010;362:896–905.
- Namazi MR. Treatment of pediculosis capitis with thiabendazole: A pilot study. Int J Dermatol. 2003;42:973–976.
- Allègre T, Cailleres S, Lota I, Tadrist Z, Coulet F, Bellon O, [Value of thiabendazole in scabies resistant to local treatment in HIV infected patients.] Presse Med. 1992;21:1821–1822.
- Akisu C, Delibas SB, Aksoy U. Albendazole: Single or combination therapy with permethrin against pediculosis capitis. Pediatr Dermatol. 2006;23:179–182.
- Douri T, Shawaf AZ. Treatment of crusted scabies with albendazole: A case report. Dermatol Online J. 2009;15:17.
- Biagi F, Delgado y Garnica R. First therapeutic trials in the treatment of scabies with thiabendazole cream. Int J Dermatol. 1974;13:102–103.
- Hernandez-Perez E. Topically applied thiabendazole in the treatment of scabies. Arch Dermatol. 1976;112:1400–1401.
- Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of helminthiasis. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill Press; 2001. p. 1121–1140.